首页> 外文OA文献 >PMH39 Estimating the cost-effectiveness of Vortioxetine versus Desvenlafaxine as first line Therapy for mild to moderate Major depressive Disorder in remitted patients

【2h】

PMH39 Estimating the cost-effectiveness of Vortioxetine versus Desvenlafaxine as first line Therapy for mild to moderate Major depressive Disorder in remitted patients

机译：PMH39评估伏立西汀与去甲文拉法辛作为缓解患者轻度至中度严重抑郁症的一线治疗的成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Keyloun K.R.; Devine B.;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. COST-EFFECTIVENESS EVALUATION, INCLUDING COGNITIVE OUTCOMES, OF VORTIOXETINE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER SWITCHING FROM FIRST ANTIDEPRESSANT THERAPY IN THE UNITED STATES [J] . Frangois C., Atsou K., Diamand F., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：从美国第一抗抑郁治疗转换的主要抑郁症患者中，vortioxetine的成本效益评估（包括认知结果）
2. COST-EFFECTIVENESS EVALUATION, INCLUDING COGNITIVE OUTCOMES, OF VORTIOXETINE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER SWITCHING FROM FIRST ANTIDEPRESSANT THERAPY IN THE UNITED STATES [J] . Frangois C., Atsou K., Diamand F., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：从美国第一抗抑郁治疗转换的主要抑郁症患者中，vortioxetine的成本效益评估（包括认知结果）
3. Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study) [J] . Rubio-Valera Maria, Teresa Penarrubia-Maria Maria, Iglesias-Gonzalez Maria, The European journal of health economics: HEPAC : health economics in prevention and care . 2019,第5期

机译：抗抑郁药的成本效益对轻度至中等重大抑郁症的主动监测：初级保健中的多路无随机对照试验（Infap Shogion）
4. Toward the Precision Medicine for a Psychiatric Disorder: Light Therapy for Major Depressive Disorder with Neuroimaging Validation [C] . Fan-pei Gloria Yang, Wei-cheng Chao, Sung-wei Chen International Conference on Biomedical and Health Informatics . 2020

机译：对精神疾病进行精密药物：对神经影像学验证的主要抑郁障碍的光疗
5. Using Early Changes in Cognition to Predict Response to 8-week Vortioxetine Treatment in Patients with Major Depressive Disorder [D] . Park, Caroline. 2019

机译：利用认知的早期变化预测对主要抑郁症患者8周Vortioxetine治疗的反应
6. Incidence and Timing of Taper/Posttherapy–Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 mg/d in Patients With Major Depressive Disorder [O] . Philip T. Ninan, Jeff Musgnung, Michael Messig, 2015

机译：重度抑郁症患者中停用去甲文拉法辛50 mg / d后逐渐减少的锥度/治疗后发生的时间和时间
7. Successfully treated patients with vortioxetine versus venlafaxine: a simplified cost-effectiveness analysis based on a head-to-head study in Asian patients with major depressive disorder [O] . Gang Wang, Kun Zhao, Caroline Reynaud-Mougin, 2020

机译：成功治疗Vorioxetine对Venlafaxine的患者：基于亚洲主要抑郁症患者的头脑研究的简化成本效益分析

PMH39 Estimating the cost-effectiveness of Vortioxetine versus Desvenlafaxine as first line Therapy for mild to moderate Major depressive Disorder in remitted patients

著录项

引文网络

相似文献

相关主题

期刊订阅